Toggle Dropdown
Announcements
Projects
News & Events
Welcome guest
Log in
Loading
Loading...
Announcements
Projects
Orgs
Project
Articles 35
Votes 0
FDA.gov
Home
Members
Articles
Authors
3
Office of the Commissioner
Office of Regulatory Affairs
Human Foods Program
1
2
Next
»
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs - fda.gov
7d
Organizations Removing Petroleum Based Food Dyes from Their Products - fda.gov
3mo
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients - fda.gov
3mo
FDA Embraces Radical Transparency by Publishing Complete Response Letters - fda.gov
4mo
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease - FDA.gov
almost2y
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors - FDA.gov
almost2y
FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus - FDA.gov
almost2y
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases - FDA.gov
~2y
FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants - FDA.gov
~2y
FDA Establishes New Advisory Committee on Digital Health Technologies - FDA.gov
~2y
FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders - FDA.gov
~2y
FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types - FDA.gov
~2y
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies - FDA.gov
~2y
FDA Approves First Biosimilar to Treat Multiple Sclerosis - FDA.gov
~2y
FDA Names First Deputy Commissioner for Proposed, Unified Human Foods Program - FDA.gov
~2y
FDA Approves First Oral Treatment for Postpartum Depression - FDA.gov
>2y
FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product - FDA.gov
>2y
FDA Approves New Drug to Prevent RSV in Babies and Toddlers - FDA.gov
>2y
FDA Approves First Nonprescription Daily Oral Contraceptive - FDA.gov
>2y
FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval - FDA.gov
>2y
Recall of Everest Brand Sambhar Masala and Garam Masala in the U.S. Due to Possible Health Risk - FDA.gov
>2y
FDA Approves First Gene Therapy for Adults with Severe Hemophilia A - FDA.gov
>2y
FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes - FDA.gov
>2y
FDA Approves First Gene Therapy for Treatment of Certain Patients with Duchenne Muscular Dystrophy - FDA.gov
>2y
FDA Inspection Blitz Leads to More Than 180 Warning Letters to Retailers for the Illegal Sale of Youth-Appealing Elf Bar and Esco Bars E-Cigarettes - FDA.gov
>2y
1
2
Next
»
Modal title
...
Profile
Loading profile
Loading...